Cantor Fitzgerald initiated coverage on Redhill Biopharma with a new price target

8/31/21 6:48:45 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Cantor Fitzgerald initiated coverage of Redhill Biopharma with a rating of Overweight and set a new price target of $22.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RDHL

Date	Price Target	Rating	Analyst
9/15/2021	$23.00 → $21.00	Buy	HC Wainwright & Co.
8/31/2021	$22.00	Overweight	Cantor Fitzgerald